# Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

> **NCT00143559** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 17 (actual)

## Conditions studied

- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Myeloid Leukemia
- Juvenile Myelomonocytic Leukemia
- Myelodysplastic Syndrome
- Paroxysmal Nocturnal Hemoglobinuria
- Hodgkin's Lymphoma
- Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** Systematic chemotherapy and antibodies
- **PROCEDURE:** Allogeneic stem cell transplantation
- **DEVICE:** Miltenyi CliniMACS

## Key facts

- **NCT ID:** NCT00143559
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2006-07
- **Final completion:** 2009-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2009-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143559, "Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00143559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*